1. Home
  2. CBAT vs VNRX Comparison

CBAT vs VNRX Comparison

Compare CBAT & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBAT
  • VNRX
  • Stock Information
  • Founded
  • CBAT 1999
  • VNRX N/A
  • Country
  • CBAT China
  • VNRX United States
  • Employees
  • CBAT 1463
  • VNRX N/A
  • Industry
  • CBAT Industrial Machinery/Components
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • CBAT Miscellaneous
  • VNRX Health Care
  • Exchange
  • CBAT Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • CBAT 102.5M
  • VNRX 52.4M
  • IPO Year
  • CBAT N/A
  • VNRX N/A
  • Fundamental
  • Price
  • CBAT $1.16
  • VNRX $0.81
  • Analyst Decision
  • CBAT
  • VNRX Strong Buy
  • Analyst Count
  • CBAT 0
  • VNRX 5
  • Target Price
  • CBAT N/A
  • VNRX $3.88
  • AVG Volume (30 Days)
  • CBAT 310.3K
  • VNRX 336.8K
  • Earning Date
  • CBAT 08-08-2025
  • VNRX 08-13-2025
  • Dividend Yield
  • CBAT N/A
  • VNRX N/A
  • EPS Growth
  • CBAT N/A
  • VNRX N/A
  • EPS
  • CBAT 0.00
  • VNRX N/A
  • Revenue
  • CBAT $152,731,078.00
  • VNRX $1,308,361.00
  • Revenue This Year
  • CBAT $28.79
  • VNRX $563.72
  • Revenue Next Year
  • CBAT $36.77
  • VNRX $160.43
  • P/E Ratio
  • CBAT $12,978.44
  • VNRX N/A
  • Revenue Growth
  • CBAT N/A
  • VNRX 64.16
  • 52 Week Low
  • CBAT $0.57
  • VNRX $0.40
  • 52 Week High
  • CBAT $1.45
  • VNRX $0.94
  • Technical
  • Relative Strength Index (RSI)
  • CBAT 64.33
  • VNRX 67.55
  • Support Level
  • CBAT $1.07
  • VNRX $0.40
  • Resistance Level
  • CBAT $1.23
  • VNRX $0.75
  • Average True Range (ATR)
  • CBAT 0.06
  • VNRX 0.10
  • MACD
  • CBAT -0.00
  • VNRX 0.02
  • Stochastic Oscillator
  • CBAT 71.43
  • VNRX 82.00

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: